SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors speculate on potential global expansion news, following previous comments by leadership regarding developments in July. While community sentiment is split between anticipation of major partnerships and frustration over the stock's recent volatility, the broader discussion is focused on the company's progress with its Anktiva therapy and upcoming quarterly earnings.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently the subject of intense community debate as investors weigh the stock's recent price volatility against the successful deployment of Starlink V3 satellites during its thirteenth Starship flight test. Market participants are primarily focused on the potential impact of upcoming lock-up expirations, with bullish investors highlighting institutional accumulation and long-term infrastructure value while bears warn of high valuations and persistent negative free cash flow.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant downward pressure as investors express skepticism toward its aggressive AI infrastructure spending, heavy debt load, and the financial stability of its key partnerships. While bulls point to robust enterprise demand and potential government-backed tailwinds, the community is deeply divided, with many debating whether the stock is a deep-value opportunity or approaching further capitulation.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin remains a highly polarized asset as investors debate its long-term viability amid concerns over leadership, lack of visible utility, and the emergence of related projects. While long-term holders continue to accumulate on price dips citing conviction in the project's roadmap, critics frequently characterize it as a stagnant or abandoned asset, with community sentiment split between those calling for a breakout and those warning of further downside.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is gaining positive momentum as investors pivot toward high-quality, cash-generating assets, bolstered by the company's strong fiscal results, resilient global payment volumes, and a new multi-billion dollar share repurchase program. The stock is a primary focus for those looking for durable market leaders, with sentiment improving as the company successfully integrates AI and stablecoin capabilities into its core payment infrastructure.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is currently a focal point for investors as the company prepares for upcoming earnings and expands its reach through new product launches, including a premium credit card and integrated AI trading agents. The community remains divided between long-term bulls highlighting Robinhoods evolving prediction markets and tokenization efforts, and active traders expressing frustration over recent price volatility and concerns about potential earnings performance.

Albertsons Cos., Inc. engages in the operation of food and drug retail stores. It offers grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. The company was founded by Joe Albertson on July 21, 1939 and is headquartered in Boise, ID.

Albertsons Companies Inc - Ordinary Shares - Class A

Albertsons is trending as investors react to the court-ordered blocking of its long-pending merger with Kroger, an outcome that has triggered significant volatility and a decline to new 52-week lows. While some community members view the collapse of the deal as a major setback, others are actively debating whether the current price represents an attractive entry point given the expected breakup fee and the company's standalone profitability.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery and Paramount Skydance are facing intensified regulatory scrutiny and potential antitrust lawsuits from a coalition of state attorneys general, creating significant uncertainty around the future of their multi-billion dollar merger. The community is actively debating the financial risks of ticking fees, the potential for bankruptcy or fire sales if the deal stalls, and whether this consolidation is a necessary evolution to compete with major streaming rivals.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap is seeing renewed attention as traders anticipate a major governance vote on the 'UNIfication' proposal, which aims to activate a fee switch and implement a significant token burn. Community discussions are heavily focused on the potential for reduced supply and the protocol's long-term utility as a decentralized liquidity layer, with many participants actively monitoring the vote's progress for signs of a breakout.

Tidal Trust II - Defiance Daily Target 2x Long MSTR ETF

Defiance Daily Target 2x Long MSTR ETF

MSTX is trending as investors debate its viability as a leveraged play on MSTR, with the community polarized between those viewing current levels as a deep-discount entry point and others cautioning against volatility decay and the potential for reverse stock splits. The conversation remains heavily tied to broader Bitcoin price action, with bulls actively looking for bounce opportunities while bears continue to highlight the risks inherent in the fund's structure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ABUS Stock On Track For Best Day In About Two Months — What’s The Moderna Connection?

Equity

On July 8, Arbutus received around $178 million from Moderna as part of a patent litigation settlement, the company said.


ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week

Arbutus expects to receive around $179 million from Moderna. 


Moderna's Revenues See Strong International Momentum in Q1 Earnings

MRNA's Q1 revenues soar 260% on strong international vaccine sales, while cost cuts and new EU approvals support its broader growth strategy.

QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures up, QuidelOrtho shares down in pre-market trading. Allbirds, MIND, Arbutus Biopharma among other stocks also falling.read more...

Arbutus Biopharma (NASDAQ:ABUS) Sees Large Volume Increase - Here's Why

Arbutus Biopharma (NASDAQ:ABUS) Sees Large Volume Increase - What's Next...

Arbutus Biopharma (NASDAQ:ABUS) Stock Price Crosses Above 200-Day Moving Average - What's Next?

Arbutus Biopharma (NASDAQ:ABUS) Share Price Passes Above 200 Day Moving Average - Time to Sell...

Arbutus Biopharma (NASDAQ:ABUS) Posts Earnings Results

Arbutus Biopharma (NASDAQ:ABUS - Get Free Report) posted its quarterly earnings data on Monday. The biopharmaceutical company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.06) by $0.05. The business had revenue of $1.05 million for the quarter, compared to...

Arbutus Biopharma (ABUS) Projected to Post Quarterly Earnings on Thursday

Arbutus Biopharma (NASDAQ:ABUS) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-arbutus-biopharma-co-stock...

Foursixthree Capital LP Has $8.99 Million Stake in Arbutus Biopharma Corporation $ABUS

Foursixthree Capital LP decreased its holdings in shares of Arbutus Biopharma Corporation (NASDAQ:ABUS - Free Report) by 22.6% during the 3rd quarter, according to the company in its most recent Form...

Arbutus Biopharma (NASDAQ:ABUS) Shares Down 8.4% - Time to Sell?

Arbutus Biopharma (NASDAQ:ABUS) Trading Down 8.4% - What's Next...

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Arbutus Biopharma Corp

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$4.38
Prev Close	$4.47
Open	$4.46
Dividend Yield	0.00%
50-Day Moving Average	$4.51
Beta	0.93
Avg. Volume	2.35M
PE Ratio	5.33

52-Week High	$5.38
52-Week Low	$3.25
Market Capitalization	$865.22M
EPS (Annual)	-$0.1748
Price to Book	3.32
Revenue Per Employee	$741,210.53

Feed

News

Sentiment

Earnings

Fundamentals

Info

ABUSArbutus Biopharma Corp

Latest ABUS News